Documents

Displaying 1 - 20 of 86 results
 
Collapse Filters
 
Expand Filters         +
April 7, 2020

Adjustment to DEA Aggregate Production Quota in Support of Coronavirus Pandemic

The Drug Enforcement Administration is adjusting the 2020 aggregate production quotas for certain controlled substances in schedule II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine. This increase is in response to the current nationwide COVID-19 public health emergency as declared by the Secretary of Health and Human Services on January 31, 2020.

March 3, 2020

Statement of Thomas Prevoznik, Deputy Assistant Administrator, Diversion Control Division: Combatting an Epidemic: Legislation to Help Patients With Substance Use Disorders

Statement of Thomas Prevoznik Deputy Assistant Administrator Diversion Control Division Drug Enforcement Administration U.S. Department of Justice Before the Subcommittee on Health House Committee on Energy and Commerce U.S. House of Representatives at a hearing entitled “Combatting an epidemic: legislation to help patients with substance use disorders” presented March 3, 2020

July 16, 2019

Statement Before House of Representatives Subcommittee on "Oversight of Federal Efforts to Combat the Spread of Illicit Fentanyl"

Statement of Matthew Donahue before the House of Representatives, Energy and Commerce Committee, Subcommittee on Oversight and Investigations for a hearing entitled, Oversight of Federal Efforts to Combat the Spread of Illicit Fentanyl.

June 4, 2019

Greg Cherundolo The Countdown: Fentanyl Analogues and the Expiring Emergency Scheduling Order

Greg Cherundolo Chief of Operations Office of Global Enforcement Drug Enforcement Administration U.S. Department of Justice before the United States Senate Judiciary Committee for hearing entitled:  The Countdown: Fentanyl Analogues and the Expiring Emergency Scheduling Order.

April 9, 2019

Greg Cherundolo Unprecendented Migration at the U.S. Southern Border: Perspectives from the Frontline

Greg Cherundolo Chief of Operations Office of Global Enforcement Drug Enforcement Administration U.S. Department of Justice before the United States Senate Homeland Security and Governmental Affairs Committee

December 12, 2018

Paul E. Knierim Narcos: Transnational Cartels and Border Security

Statement of Paul E. Knierim Deputy Chief of Operations, Office of Global Enforcement Drug Enforcement Administration Before the Subcommittee on Border Security and Immigration Committee on the Judiciary United States Senate

October 2, 2018

Paul E. Knierim “Stopping the Poison Pills: Combatting the Trafficking of Illegal Fentanyl from China”

Statement before the Caucus on International Narcotics Control United States Senate for a hearing entitled “Stopping the Poison Pills: Combatting the Trafficking of Illegal Fentanyl from China”

September 6, 2018

Paul E. Knierim - Tackling Fentanyl: The China Connection

Statement of Paul E. Knierim Deputy Chief of Operations, Office of Global Enforcement Before the Subcommittee on Africa, Global Health, Global Human Rights and International Organizations Committee on Foreign Affairs U.S. House of Representatives for a hearing entitled "Tackling Fentanyl: The China Connection"

DEA US Badge
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice